ACB $7.560 (-0.53%)

ACNNF $0.250 (-1.96%)

AERO $1.350 (5.47%)

AGEEF $0.460 (3.35%)

ALEAF $0.946 (-0.42%)

AMMJ $0.260 (-1.14%)

APHA $6.810 (-0.87%)

ARNA $58.410 (2.06%)

ATT:CNX $0.080 (0%)

ATTBF $0.032 (0%)

AUSA:CNX $1.010 (-1.94%)

AUSAF $0.758 (-0.64%)

AVXL $3.280 (4.46%)

BAMM:CNX $1.440 (0.7%)

BBM:CNX $0.380 (-5%)

BBRRF $0.293 (-0.81%)

BE:CNX $0.080 (0%)

BIO:CNX $0.480 (2.13%)

BLEVF $0.060 (-7.69%)

BLIS:CNX $0.360 (1.41%)

BLO:CNX $1.320 (1.54%)

BLOZF $0.971 (1.11%)

BUDZ $0.640 (0.71%)

BXNG $0.530 (20.43%)

CADMF $1.528 (7.57%)

CALI:CNX $0.120 (-7.69%)

CANN $0.830 (-3.77%)

CARA $19.830 (-0.05%)

CBII:CNX $0.170 (0%)

CBWTF $0.550 (-2.2%)

CGC $42.040 (0.41%)

CGRW $0.385 (-5.41%)

CHOO:CNX $0.475 (-2.06%)

CHOOF $0.358 (-2.32%)

CNAB $0.364 (-3%)

CNBX $0.280 (0.36%)

CNGGF $1.329 (-7.74%)

CODI $18.400 (-3.66%)

CPMD $1.890 (1.61%)

CRBP $7.020 (-1.4%)

CRON $15.710 (-0.88%)

CROP:CNX $0.210 (-2.33%)

CRTPF $4.084 (-3.43%)

CRXPF $0.155 (-3.13%)

CSI:CNX $2.030 (7.41%)

CTST $4.930 (-1.4%)

CURR $4.105 (1.86%)

CVSI $4.105 (-1.32%)

DIGP $0.136 (-11.79%)

DXBRF $0.740 (4.83%)

EAPH $0.005 (4.26%)

EAT:CNX $0.195 (0%)

EEVVF $0.288 (-0.84%)

EMHTF $2.070 (3.5%)

EPWCF $0.100 (-9.09%)

EVIO $0.391 (56.4%)

FFRMF $0.075 (0%)

FFT:CNX $0.105 (5%)

FNNZF $0.096 (6.78%)

FSDDF $0.122 (-5.85%)

GGTTF $0.360 (-3.12%)

GLDFF $0.050 (-12.28%)

GLH:CNX $0.060 (-14.29%)

GLNNF $0.104 (-0.19%)

GNBT $1.760 (6.67%)

GRIN:CNX $0.210 (2.44%)

GRWG $3.120 (0.65%)

GSTR:CNX $0.260 (6.12%)

GTBIF $10.100 (-0.98%)

GTII:CNX $13.530 (-0.73%)

GWPH $176.000 (3.33%)

HC:CNX $0.290 (7.41%)

HEXO $5.550 (0.73%)

HHPHF $0.222 (7.3%)

HLSPY $0.530 (-18.45%)

HMLSF $13.971 (0.94%)

HMPPF $0.631 (0.53%)

HRVOF $0.450 (-7.16%)

HSTRF $0.267 (-2.09%)

HUGE:CNX $0.170 (3.03%)

IAN:CNX $4.380 (-6.61%)

IGC $1.230 (2.5%)

IGXT $0.492 (-3.63%)

IIPR $119.600 (3.2%)

IMLFF $0.250 (-3.74%)

INQD $0.021 (-4.11%)

INSY $0.291 (-1.36%)

IONC:CNX $0.380 (5.56%)

ISOL:CNX $1.030 (-0.96%)

ISOLF $0.782 (0.62%)

ITHUF $3.312 (-5.37%)

IVITF $0.297 (-3.03%)

JWCAF $0.593 (-0.92%)

KALTF $0.039 (8.33%)

KBEV:CNX $0.370 (2.78%)

KBEVF $0.280 (6.78%)

KHRNF $1.699 (-5.09%)

KSHB $4.338 (-1.42%)

LDS:CNX $0.375 (-10.71%)

LDSYF $0.282 (-5.43%)

LHS:CNX $0.590 (-1.67%)

LHSIF $0.456 (1.49%)

LOVE:CNX $0.165 (-2.94%)

LVWL:CNX $0.740 (0%)

LXLLF $0.550 (0%)

LXRP $0.870 (0%)

LXX:CNX $1.180 (2.61%)

MCIG $0.054 (-5.26%)

MDCL $3.900 (-0.26%)

MEDIF $3.980 (0.89%)

MGWFF $0.100 (5.26%)

MICWF $0.230 (-3%)

MJ:CNX $0.450 (0%)

MJNA $0.054 (-4.96%)

MNTR $0.299 (-12.51%)

MRRCF $0.531 (-0.79%)

MWM:CNX $0.280 (-8.2%)

MYM:CNX $0.280 (-3.45%)

MYMMF $0.211 (-6.22%)

NCNNF $0.650 (-0.64%)

NDVAF $0.300 (-2.76%)

NGW:CNX $0.310 (-7.46%)

NRXCF $0.049 (10.06%)

NSPDF $0.077 (-14.33%)

NTEC $4.780 (-0.42%)

NVTQF $0.013 (0%)

NWKRF $0.424 (0%)

NXGWF $0.231 (-7.99%)

NXTTF $0.475 (1.16%)

OGI $6.440 (3.54%)

OH:CNX $9.000 (3.45%)

ORHOF $6.670 (3.23%)

OWCP $0.014 (-4.76%)

PHGI:CNX $0.380 (-5%)

PHGRF $0.300 (4.53%)

PHVAF $0.309 (0.53%)

PILL:CNX $0.710 (1.43%)

PKG:CNX $0.235 (-4.08%)

PLPRF $2.910 (-3%)

PLUS:CNX $3.910 (-2.98%)

PMCB $0.038 (-3.8%)

PNPL $0.500 (0%)

POTN $0.074 (-7.7%)

PRCNF $0.094 (6.68%)

PTNYF $0.185 (-0.22%)

PUFXF $0.287 (6.02%)

QCA:CNX $0.200 (0%)

RDDTF $0.665 (-3.6%)

RLLVF $0.065 (-4.46%)

RMHB $0.053 (-7.02%)

RQB:CNX $0.540 (-5.26%)

RQHTF $0.197 (10.09%)

RVVQF $0.415 (0.59%)

SLNG:CNX $1.590 (4.61%)

SMG $98.170 (1.34%)

SNN:CNX $2.980 (-1%)

SNNVF $2.224 (-0.75%)

SOL:CNX $2.130 (-2.74%)

SOLCF $1.600 (-1.84%)

SPLIF $0.148 (-2.25%)

SPRWF $1.150 (-0.82%)

SRNA $0.046 (-0.25%)

STEM:CNX $2.070 (0.98%)

STMH $1.482 (-4.39%)

SUN:CNX $0.610 (-1.61%)

TBPMF $0.358 (-0.13%)

TCAN:CNX $5.140 (3.84%)

TDRYF $0.309 (0%)

TER:CNX $5.950 (-0.83%)

TGEN $3.540 (3.81%)

TGIF:CNX $0.450 (0%)

TGIFF $0.341 (1.07%)

THC:CNX $0.240 (-4%)

THCBF $0.177 (-7%)

TLRY $41.050 (1.58%)

TOKI:CNX $0.130 (4%)

TRLFF $0.337 (-2.38%)

TRPX $2.520 (-8.36%)

TRSSF $4.470 (0.68%)

TRTC $0.620 (2.92%)

TURV $0.445 (1.14%)

VAPN:CNX $1.870 (0%)

VBIO $0.240 (0%)

VIDA:CNX $0.415 (2.47%)

VIN:CNX $0.520 (0%)

VPRB $0.060 (-2.12%)

VRNDF $0.863 (-3.77%)

VRT:CNX $0.425 (8.97%)

VRTHF $0.266 (-3.93%)

VVCIF $0.398 (-8.59%)

WAYL:CNX $0.740 (0%)

WDDMF $1.064 (-5.88%)

WLDFF $0.470 (-3.07%)

XXII $2.030 (-6.45%)

ZDPY $0.300 (0%)

ZYNE $13.790 (2.76%)

Technical420 Site Search

Returned 13 result(s).

Halo Labs to Expand Globally and Acquire Bophelo Bioscience

Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into a non-binding letter of intent (LOI) for the proposed acquisition of Bophelo Bioscience & Wellness (Pty) Ltd (“Bophelo”) (the “Transaction”). The Transaction is expected to strengthen the Company’s…

Halo Labs Issues Corporate Update

Halo Labs Inc. (NEO:HALO, OTCQX:AGEEF) is pleased to announce a corporate update on various matters. United States Operations and Partnerships by State California Halo continues its expansion in the California market. The Company commenced operations in the state in late 2018. Bulk product sales started in January 2019. White label…

WeedMD to Convert Aylmer Facility to Cannabis Extraction and Processing Hub

WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it is converting its fully-licensed 26,000 sq. ft. Aylmer, Ontario facility to a large-scale cannabis extraction and processing operation. “WeedMD is optimizing its two licensed facilities to allow each to focus on a…

Halo Labs Announces Strategic Partnership with High Tide for Exclusive Distribution of DabTabsTM Home Preparation Kits

Halo Labs Inc. (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has partnered with High Tide Inc. (CSE: HITI, OTCQB: HITIF, FRA: 2LY) to introduce Halo-produced products through High Tide’s distribution channels. High Tide has an extensive distribution network throughout Canada, the United States and Europe with…

The Proof Is In The Numbers For Halo Labs

Cannabis concentrates have been one of the hottest opportunities for cannabis businesses as demand for these products continues to increase. This is a trend that we have been closely following as it was been creating massive value for the companies that are capitalizing on the cannabis concentrate opportunity. Halo Labs…

MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce first quarter financial results for the three months ended March 31, 2019. The consolidated financial statements and management's discussion…

Halo Labs Is Expanding Into The CBD Vertical

Earlier this month, we featured Halo Labs (HALO: NEO) (AGEEF: OTC) as a company that has been capitalizing on the cannabis oil opportunity in the United States and we hope that you paid attention to this. Halo Labs recently reported several significant developments and the market has responded favorably to…

IONIC Brands Signs LOI to Acquire Licensed Cannabis Volatile Extraction and Manufacturing Assets of Kavry Managment LLC

IONIC Brands Corp., formerly Zara Resources Inc. (CSE: IONC) ("IONIC BRANDS" or the "Company") announces today that it has entered into a Letter of Intent ("LOI") to acquire licensed cannabis volatile extraction and manufacturing assets of Kavry Management LLC ("Kavry"). IONIC BRANDS signed a LOI dated April 4, 2019 with…

MediPharm Labs Announces OTC Ticker Symbol Change to “MEDIF”

MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, today announced FINRA has approved a change in the Company’s stock symbol trading on the OTCQB Markets. Effective today, the Company's common shares…

MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million

MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce fourth quarter and full year financial results for the year ended December 31, 2018. The audited consolidated financial statements…

Older Posts »

Search Again